A study of CSF catecholamine and its metabolites in acute and convalescent period of encephalitis

Journal of the Neurological Sciences

Volumn 252, Issue 1, 2007, Pages 62-66

  Kalita, J ^a   Kumar, S ^a   Vijaykumar, K ^b   Palit, G ^b   Misra, U K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

CSF catecholamine; Dopamine; Dystonia; Encephalitis; Movement disorder; MRI; Norepinephrine; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CATECHOLAMINE; DOPAMINE; NORADRENALIN; SEROTONIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; DOPAMINE BLOOD LEVEL; DYSTONIA; ENCEPHALITIS; EPIDEMIC ENCEPHALITIS; GLASGOW COMA SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLITE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NORADRENALIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; SEIZURE; SEROTONIN BLOOD LEVEL; VIROLOGY;

3,4-DIHYDROXYPHENYLACETIC ACID; ADOLESCENT; ADULT; AGE FACTORS; AGED; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENCEPHALITIS; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HOMOVANILLIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 33845458902     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.10.010     Document Type: Article

References (18)

1. Misra U.K., Kalita J., Jain S.K., and Mathur A. Radiological and neurophysiological changes in Japanese encephalitis. J Neurol Neurosurg Psychiatry 57 (1994) 1484-1487
2. Misra U.K., and Kalita J. Movement disorders in Japanese encephalitis. J Neurol 244 (1997) 299-303
3. Misra U.K., and Kalita J. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med J 78 (2002) 238-241
4. Kalita J., Misra U.K., Pandey S., and Dhole T.N. A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol 60 (2003) 1760-1764
5. Greenfield J.G., and Bosanquet F.D. The brain-stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry 16 (1953) 213-226
6. Riederer P., Birkmayer W., Seemann D., and Wuketich S. Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome. J Neural Transm 41 (1977) 241-251
7. Murai T., Muller U., Werheid K., Sorger D., Reuter M., Becker T., et al. In vivo evidence for differential association of striatal dopamine and midbrain serotonin system with neuropsychiatric symptoms in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 222-228
8. Piccini P., and Brooke D.J. Etiology of Parkinson's disease contributions from 18F-Dopa positron emission tomography. Adv Neurol 80 (1999) 227-230
9. Booij T., Tissingh G., and Boer G. [131]FP-SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 62 (1997) 133-140
10. Parkinson Study Group. Cerebrospinal homovanillic acid in DATATOP study on Parkinson's disease. Arch Neurol 52 (1995) 237-245
11. Kalita J., and Misra U.K. Markedly severe dystonia in Japanese encephalitis. Mov Disord 15 (2000) 1168-1172
12. Misra U.K., Kalita J., Pandey S., Khanna V.K., and Babu G.N. Cerebrospinal fluid catecholamine levels in Japanese encephalitis patients with movement disorders. Neurochem Res 30 (2005) 1075-1078
13. Meyer J.S., Stoica E., Shimazu K., and Hartman A. catecholamine concentration in CSF and plasma of patients with cerebral infarction and haemorrhage. Brain 96 (1973) 277-288
14. Fahn S. Clinical variants of idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry (1989) S96-S100
15. Fahn S., and Elton R.L. Unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., and Goldstein D.S. (Eds). Recent developments in Parkinson's disease (1987), Macmillian, New York 153-163
16. Segawa M., and Nomura Y. A pathophysiology of hereditary progressive dystonia with marked diurnal fluctuation: its characteristics in contrast to other dopa responsive disorders. In: Fisher A., Hanin I., and Yoshida M. (Eds). Progress in Alzhimer's and Parkinsons diseases (1998), Plenum Press, New York, NY 363-370
17. LeWitt P.A., Galloway M.P., Matson W., Milbury P., McDermott M., Srivastava D.K., et al. Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group. Neurology 42 (1992) 2111-2117
18. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., and Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20 (1973) 415-455